Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05787 (P05712)
Organon and Co · Pregnancy · Neonates
Not applicable
Completed
541
2024-09
Industry sponsor intelligence
Organon and CoClinical Pipeline.
Lead-sponsor view of Organon and Co's indexed peptide studies, development phases, active programs, completed work and recent registry changes.
- Total
- 14
- Recruiting
- 0
- Active
- 0
- Completed
- 13
- Results posted
- 8
- Avg enrollment
- 1,533
Pipeline overview
Programs by phase and activity.
Velocity
Organon and Co trials by start year
Study start year · indexed snapshot
Development
Trials by phase
8phase labels
Early Phase 10
Phase 10
Phase 23
Phase 35
Phase 40
| Product | Studies | Early / I | Phase II | Phase III | Phase IV | Active |
|---|---|---|---|---|---|---|
| Ganirelix → | 13 | 0 | 3 | 4 | 0 | 0 |
| Eptifibatide → | 1 | 0 | 0 | 1 | 0 | 0 |
Active peptide trials
In motion now.
No studies in this snapshot.
Completed trials
Finished registry records.
NCT IDStudyPhase / statusEnrollmentUpdated
Follow-up Study of Frozen-thawed Embryo Transfer (FTET) Cycles After Cryopreservation of Embryos in Clinical Trial P05787 (P05716)
Organon and Co · In Vitro Fertilization
Not applicable
Completed
344
2024-09
A Phase 2, Trial to Investigate the Dose-Response Relationship of a Single Injection of Org 36286 (Corifollitropin Alfa) to Initiate Multiple Follicular Growth in a Controlled Ovarian (Study 38826)(P06055)(COMPLETED)
Organon and Co · Fertilization
Phase 2
Completed
325
2024-08
Investigate Dose of Org 36286 to Initiate Multiple Follicular Growth in a Controlled Ovarian Hyperstimulation Protocol for IVF or IVF/ICSI (P07015)
Organon and Co · Infertility · In Vitro Fertilization
Phase 2
Completed
99
2024-08
Japanese Bridging Trial of Org 37462 (Study P05969)(COMPLETED)
Organon and Co · Controlled Ovarian Stimulation
Phase 2
Completed
266
2024-08
A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)
Organon and Co · In Vitro Fertilization
Phase 3
Completed
1,509
2024-06
To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Ensure)(P05690/MK-8962-001)
Organon and Co · Infertility
Phase 3
Completed
397
2024-06
EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non-ST-segment Elevation Acute Coronary Syndrome (Study P03684AM2)(COMPLETED)
Organon and Co · Myocardial Ischemia · Acute Coronary Syndrome
Phase 3
Completed
9,406
2024-05
Post-Marketing Surveillance of the Safety and Efficacy of Orgalutran (Ganirelix)®
Organon and Co · Fertilization in Vitro
Not applicable
Completed
711
2024-04
Follow-up Protocol on the Outcome of Frozen-thawed Embryo Transfer Cycles From Clinical Trial P05690 (P05711)
Organon and Co · In Vitro Fertilization
Not applicable
Completed
102
2022-02
Showing 10 of 13 studies
Search sponsor records
All Organon and Co studies.
This page groups studies where Organon and Co is listed as the lead industry sponsor. Collaborator-only records are not included in the count.
14 matching studies
Last registry update first
Recent updates
Latest registry movement.
NCT00703014Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05787 (P05712)Sep 19, 2024NCT00702273Follow-up Study of Frozen-thawed Embryo Transfer (FTET) Cycles After Cryopreservation of Embryos in Clinical Trial P05787 (P05716)Sep 5, 2024NCT00598208A Phase 2, Trial to Investigate the Dose-Response Relationship of a Single Injection of Org 36286 (Corifollitropin Alfa) to Initiate Multiple Follicular Growth in a Controlled Ovarian (Study 38826)(P06055)(COMPLETED)Aug 15, 2024NCT00702806Investigate Dose of Org 36286 to Initiate Multiple Follicular Growth in a Controlled Ovarian Hyperstimulation Protocol for IVF or IVF/ICSI (P07015)Aug 15, 2024NCT00988260Japanese Bridging Trial of Org 37462 (Study P05969)(COMPLETED)Aug 15, 2024NCT00696800A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)Jun 20, 2024NCT00702845To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Ensure)(P05690/MK-8962-001)Jun 18, 2024NCT00089895EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non-ST-segment Elevation Acute Coronary Syndrome (Study P03684AM2)(COMPLETED)May 17, 2024NCT01304511Post-Marketing Surveillance of the Safety and Efficacy of Orgalutran (Ganirelix)®Apr 3, 2024NCT00702546Follow-up Protocol on the Outcome of Frozen-thawed Embryo Transfer Cycles From Clinical Trial P05690 (P05711)Feb 3, 2022